FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127496710> ?p ?o ?g. }

• W2127496710 abstract "Ovarian cancer is one of the most significant malignancies in the western world. Studies showed that Ovarian cancers tend to grow resistance to cisplatin treatment. Therefore, new approaches are needed in ovarian cancer treatment. Kaempferol is a dietary flavonoid that is widely distributed in fruits and vegetables, and epidemiology studies have revealed a protective effect of kaempferol against ovarian cancer risk. Our early studies also found that kaempferol is effective in reducing vascular endothelial growth factor (VEGF) expression in ovarian cancer cells. In this study, we investigated kaempferol's effects on sensitizing ovarian cancer cell growth in response to cisplatin treatment.Ten chemicals were screened for sensitizing OVCAR-3 ovarian cancer cell growth in response to cisplatin treatment. For kaempferol, which shows a significant synergistic interaction with cisplatin, expression of ABCC1, ABCC5, ABCC6, NFkB1, cMyc, and CDKN1A genes was further examined. For cisplatin/kaempferol treatments on OVCAR-3 cancer cells, the mRNA levels of ABCC1, ABCC5, and NFkB1 did not change. However, significant inhibition of ABCC6 and cMyc mRNA levels was observed for the cisplatin/kaempferol combined treatment. The CDKN1A mRNA levels were significantly up-regulated by cisplatin/kaempferol treatment. A plot of CDKN1A mRNA levels against that of cMyc gene further revealed a reverse, linear relationship, proving cMyc's regulation on CDKN1A gene expressions. Our work found that kaempferol works synergistically with cisplatin in inhibiting ovarian cancer cell viability, and their inhibition on cell viabilities was induced through inhibiting ABCC6 and cMyc gene transcription. Apoptosis assay showed the addition of 20 muM kaempferol to the cisplatin treatment induces the apoptosis of the cancer cells.Kaempferol enhances the effect of cisplatin through down regulation of cMyc in promoting apoptosis of ovarian cancer cells. As a dietary component, kaempferol sensitizes ovarian cancer cells to cisplatin treatment and deserves further studies for possible applications in chemotherapy of ovarian cancers." @default.
• W2127496710 created "2016-06-24" @default.
• W2127496710 creator A5012584866 @default.
• W2127496710 creator A5020582877 @default.
• W2127496710 creator A5024577852 @default.
• W2127496710 creator A5026517567 @default.
• W2127496710 creator A5055653838 @default.
• W2127496710 date "2010-05-11" @default.
• W2127496710 modified "2023-10-03" @default.
• W2127496710 title "Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc" @default.
• W2127496710 cites W1544553486 @default.
• W2127496710 cites W1964742508 @default.
• W2127496710 cites W1986067341 @default.
• W2127496710 cites W2005518349 @default.
• W2127496710 cites W2011502135 @default.
• W2127496710 cites W2013886816 @default.
• W2127496710 cites W2027167686 @default.
• W2127496710 cites W2031819395 @default.
• W2127496710 cites W2042615004 @default.
• W2127496710 cites W2058390366 @default.
• W2127496710 cites W2058680827 @default.
• W2127496710 cites W2097640458 @default.
• W2127496710 cites W2107417411 @default.
• W2127496710 cites W2108034902 @default.
• W2127496710 cites W2112820588 @default.
• W2127496710 cites W2118447955 @default.
• W2127496710 cites W2142375064 @default.
• W2127496710 cites W2328421677 @default.
• W2127496710 cites W4239473509 @default.
• W2127496710 doi "https://doi.org/10.1186/1475-2867-10-16" @default.
• W2127496710 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2885998" @default.
• W2127496710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20459793" @default.
• W2127496710 hasPublicationYear "2010" @default.
• W2127496710 type Work @default.
• W2127496710 sameAs 2127496710 @default.
• W2127496710 citedByCount "94" @default.
• W2127496710 countsByYear W21274967102012 @default.
• W2127496710 countsByYear W21274967102013 @default.
• W2127496710 countsByYear W21274967102014 @default.
• W2127496710 countsByYear W21274967102015 @default.
• W2127496710 countsByYear W21274967102016 @default.
• W2127496710 countsByYear W21274967102017 @default.
• W2127496710 countsByYear W21274967102018 @default.
• W2127496710 countsByYear W21274967102019 @default.
• W2127496710 countsByYear W21274967102020 @default.
• W2127496710 countsByYear W21274967102021 @default.
• W2127496710 countsByYear W21274967102022 @default.
• W2127496710 countsByYear W21274967102023 @default.
• W2127496710 crossrefType "journal-article" @default.
• W2127496710 hasAuthorship W2127496710A5012584866 @default.
• W2127496710 hasAuthorship W2127496710A5020582877 @default.
• W2127496710 hasAuthorship W2127496710A5024577852 @default.
• W2127496710 hasAuthorship W2127496710A5026517567 @default.
• W2127496710 hasAuthorship W2127496710A5055653838 @default.
• W2127496710 hasBestOaLocation W21274967101 @default.
• W2127496710 hasConcept C121608353 @default.
• W2127496710 hasConcept C126322002 @default.
• W2127496710 hasConcept C190283241 @default.
• W2127496710 hasConcept C2776694085 @default.
• W2127496710 hasConcept C2777810353 @default.
• W2127496710 hasConcept C2778004101 @default.
• W2127496710 hasConcept C2778239845 @default.
• W2127496710 hasConcept C2779054382 @default.
• W2127496710 hasConcept C2780427987 @default.
• W2127496710 hasConcept C502942594 @default.
• W2127496710 hasConcept C55493867 @default.
• W2127496710 hasConcept C71924100 @default.
• W2127496710 hasConcept C86803240 @default.
• W2127496710 hasConcept C96232424 @default.
• W2127496710 hasConcept C98274493 @default.
• W2127496710 hasConceptScore W2127496710C121608353 @default.
• W2127496710 hasConceptScore W2127496710C126322002 @default.
• W2127496710 hasConceptScore W2127496710C190283241 @default.
• W2127496710 hasConceptScore W2127496710C2776694085 @default.
• W2127496710 hasConceptScore W2127496710C2777810353 @default.
• W2127496710 hasConceptScore W2127496710C2778004101 @default.
• W2127496710 hasConceptScore W2127496710C2778239845 @default.
• W2127496710 hasConceptScore W2127496710C2779054382 @default.
• W2127496710 hasConceptScore W2127496710C2780427987 @default.
• W2127496710 hasConceptScore W2127496710C502942594 @default.
• W2127496710 hasConceptScore W2127496710C55493867 @default.
• W2127496710 hasConceptScore W2127496710C71924100 @default.
• W2127496710 hasConceptScore W2127496710C86803240 @default.
• W2127496710 hasConceptScore W2127496710C96232424 @default.
• W2127496710 hasConceptScore W2127496710C98274493 @default.
• W2127496710 hasIssue "1" @default.
• W2127496710 hasLocation W21274967101 @default.
• W2127496710 hasLocation W21274967102 @default.
• W2127496710 hasLocation W21274967103 @default.
• W2127496710 hasLocation W21274967104 @default.
• W2127496710 hasLocation W21274967105 @default.
• W2127496710 hasOpenAccess W2127496710 @default.
• W2127496710 hasPrimaryLocation W21274967101 @default.
• W2127496710 hasRelatedWork W1992976746 @default.
• W2127496710 hasRelatedWork W1999604306 @default.
• W2127496710 hasRelatedWork W2026322528 @default.
• W2127496710 hasRelatedWork W2064215138 @default.
• W2127496710 hasRelatedWork W2068479722 @default.
• W2127496710 hasRelatedWork W2353260778 @default.
• W2127496710 hasRelatedWork W2371282176 @default.

• next